Tyrosine Kinase Inhibitor
specificA drug that interferes with cell communication and growth and may prevent tumor growth. Some tyrosine kinase inhibitors are used to treat cancer.
37
Centers
0
Active Trials
$178M
Cancer Funding
Top Centers for Tyrosine Kinase Inhibitor(37)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 68.4 |
| 2 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program | 67.4 |
| 3 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 66.5 |
| 4 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 65.5 |
| 5 | NCI Comprehensive Active Research Program | 64.6 |
| 6 | UCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco, CA NCI Comprehensive Active Research Program | 63.6 |
| 7 | NCI Comprehensive Active Research Program | 62.7 |
| 8 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 61.8 |
| 9 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 60.8 |
| 10 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 59.9 |
| 11 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 58.9 |
| 12 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive Active Research Program | 58.0 |
| 13 | Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program | 57.0 |
| 14 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 56.1 |
| 15 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 55.1 |
| 16 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 54.2 |
| 17 | NCI Comprehensive Active Research Program | 53.2 |
| 18 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 52.3 |
| 19 | NCI Comprehensive Active Research Program | 51.4 |
| 20 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 50.4 |
| 21 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 49.5 |
| 22 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 48.5 |
| 23 | Ellis Fischel Cancer Center, MU Health CareColumbia, MO Active Research Program | 47.6 |
| 24 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive Active Research Program | 46.6 |
| 25 | Active Research Program | 45.7 |
| 26 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 44.7 |
| 27 | Herbert Irving Comprehensive Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 43.8 |
| 28 | NCI Comprehensive Active Research Program | 42.8 |
| 29 | Stephenson Cancer CenterOklahoma City, OK NCI Clinical Active Research Program | 41.9 |
| 30 | NCI Comprehensive Active Research Program | 40.9 |
| 31 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 40.0 |
| 32 | UMass Memorial Health Cancer CenterWorcester, MA Active Research Program | 39.1 |
| 33 | NCI Comprehensive Active Research Program | 38.1 |
| 34 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 37.2 |
| 35 | NCI Comprehensive Active Research Program | 36.2 |
| 36 | UF Health Cancer InstituteGainesville, FL NCI Clinical Active Research Program | 35.3 |
| 37 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Contributing Research Center | 34.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →